The present invention relates to nucleic acids encoding anti-CD20 antigen binding
molecules (ABMs). In particular embodiments, the present invention relates to nucleic acid …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
49304338&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

The invention relates to novel binding domain-immunoglo bulin fusion proteins that feature a
binding domain for a cognate structure Such as an antigen, a counterreceptor or the like, a …

Multivalent binding peptides, including bi-specific binding peptides, having immunoglobulin
effector function are provided, along with encoding nucleic acids, vectors and host cells as …

Related US Application Data (60) Continuation of application No. 08/475,813, filed on Jun.
7, 1995, now Pat. No. 6,682,734, which is a divi sion of application No. 08/149,099, filed on …

5,776.456 A 7, 1998 Anderson et al. Methods are disclosed of treating rheumatoid arthritis in
a 5,786,456 A 7, 1998 Ledbetter et al. human comprising administering to the human more …

US7799900B2 - Immunoglobulin variants and uses thereof - Google Patents US7799900B2 -
Immunoglobulin variants and uses thereof - Google Patents Immunoglobulin variants and …

The present invention relates to a highly concentrated, stable pharmaceutical formulation of
a pharmaceutically active anti-CD20 antibody, such as eg Rituximab, Ocrelizumab, or …

Related US Application Data (60) Provisional application No. 60598.855, filed on
Aug.(Continued) 4, 2004, provisional application No. 60/602,953, filed on Aug. 19, 2004 …

The invention relates to novel binding domain immunoglo bulin fusion proteins that feature a
binding domain for a cognate structure Such as an antigen, a counterreceptor or the like, a …